📣 VC round data is live. Check it out!

S2Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for S2Medical and similar public comparables like Audientes, Odinwell, Standard Dental Labs, Momina Krepost and more.

S2Medical Overview

About S2Medical

S2Medical AB is a research-intensive MedTech company from Sweden. The company develops products within the entire wound healing process from debridement and granulation to re-epithelialization. products for the initial phase of a wound's healing process until the end, when the wound is completely healed. S2Medical also has in its portfolio the product NoSmell for odor removal which is procured in several different Swedish healthcare regions.


Founded

2013

HQ

Sweden

Employees

7

Website

s2m.se

Financials (FY)

Revenue: $2M
EBITDA: ($946K)

EV

$547K

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

S2Medical Financials

S2Medical reported last fiscal year revenue of $2M and negative EBITDA of ($946K).

In the same fiscal year, S2Medical generated $2M in gross profit, ($946K) in EBITDA losses, and had net loss of ($1M).


S2Medical P&L

In the most recent fiscal year, S2Medical reported revenue of $2M and EBITDA of ($946K).

S2Medical is unprofitable as of last fiscal year, with gross margin of 98%, EBITDA margin of (61%), and net margin of (70%).

See analyst estimates for S2Medical
Last FY202320242025202620272028
Revenue$2M$749K$2M$2M
Gross Profit$2M$541K$1M$2M
Gross Margin98%72%95%98%
EBITDA($946K)($1M)$660K($946K)
EBITDA Margin(61%)(194%)42%(61%)
EBIT Margin(19%)(219%)33%(19%)
Net Profit($1M)($2M)$517K($1M)
Net Margin(70%)(326%)33%(70%)

Financial data powered by Morningstar, Inc.

S2Medical Stock Performance

S2Medical has current market cap of $644K, and enterprise value of $547K.

Market Cap Evolution


S2Medical's stock price is $0.00.

S2Medical share price decreased by 5.9% in the last 30 days, and by 64.6% in the last year.

See more trading valuation data for S2Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$547K$644K0.6%-5.9%-35.8%-64.6%$-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

S2Medical Valuation Multiples

S2Medical trades at 0.4x EV/Revenue multiple, and (0.6x) EV/EBITDA.

See NTM and 2027E valuation multiples for S2Medical

S2Medical Financial Valuation Multiples

As of May 27, 2026, S2Medical has market cap of $644K and EV of $547K.

S2Medical has a P/E ratio of (0.6x).

Last FY202320242025202620272028
EV/Revenue0.4x0.7x0.3x0.4x
EV/EBITDA(0.6x)(0.4x)0.8x(0.6x)
EV/EBIT(1.9x)(0.3x)1.1x(1.9x)
EV/Gross Profit0.4x1.0x0.4x0.4x
P/E(0.6x)(0.3x)1.2x(0.6x)
EV/FCF(3.8x)(0.3x)1.0x(3.8x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified S2Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

S2Medical Margins & Growth Rates

In the most recent fiscal year, S2Medical reported gross margin of 98%, EBITDA margin of (61%), and net margin of (70%).

See estimated margins and future growth rates for S2Medical

S2Medical Margins

Last FY20242025202720282029
Gross Margin98%95%98%
EBITDA Margin(61%)42%(61%)
EBIT Margin(19%)33%(19%)
Net Margin(70%)33%(70%)
FCF Margin(9%)34%(9%)

S2Medical Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth111%(2%)
Gross Profit Growth176%1%
EBITDA Growth(145%)(243%)
EBIT Growth(132%)(155%)
Net Profit Growth(121%)(310%)
FCF Growth(128%)(127%)

Data powered by FactSet, Inc. and Morningstar, Inc.

S2Medical Operational KPIs

S2Medical's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.3M for the same period.

Access forward-looking KPIs for S2Medical
Last FY202320242025202620272028
Revenue per Employee$0.2M---
Opex per Employee$0.3M---
Opex to Revenue116%291%62%116%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

S2Medical Competitors

S2Medical competitors include Audientes, Odinwell, Standard Dental Labs, Momina Krepost, Cuprina Holdings (Cayman), BioRegenx, Airway Medix, Etropal and Balsm Alofoq.

Most S2Medical public comparables operate across Medical Supplies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Audientes----
Odinwell--(1.2x)-
Standard Dental Labs----
Momina Krepost7.1x-(7.0x)-
Cuprina Holdings (Cayman)95.4x-(1.0x)-
BioRegenx----
Airway Medix11589.3x-13.3x-

This data is available for Pro users. Sign up to see all S2Medical competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About S2Medical

When was S2Medical founded?S2Medical was founded in 2013.
Where is S2Medical headquartered?S2Medical is headquartered in Sweden.
How many employees does S2Medical have?As of today, S2Medical has over 7 employees.
Is S2Medical publicly listed?Yes, S2Medical is a public company listed on Nasdaq Stockholm.
What is the stock symbol of S2Medical?S2Medical trades under S2M ticker.
When did S2Medical go public?S2Medical went public in 2018.
Who are competitors of S2Medical?S2Medical main competitors include Audientes, Odinwell, Standard Dental Labs, Momina Krepost, Cuprina Holdings (Cayman), BioRegenx, Airway Medix, Etropal, Balsm Alofoq.
What is the current market cap of S2Medical?S2Medical's current market cap is $644K.
What is the current revenue of S2Medical?S2Medical's last fiscal year revenue is $2M.
What is the current EV/Revenue multiple of S2Medical?Current revenue multiple of S2Medical is 0.4x.
Is S2Medical profitable?No, S2Medical is not profitable.
How many companies S2Medical has acquired to date?S2Medical hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies S2Medical has invested to date?S2Medical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to S2Medical

Lists including S2Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial